Search

Author/Creator Derkach, Andriy

1. A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy. Issue 14 (6th December 2022)

Authors:
Nath, Karthik; Shekarkhand, Tala; Salcedo, Meghan; Derkach, Andriy; Rueda, Siobhan; Chansakul, Aisara; Hulcrantz, Malin; Korde, Neha; Shah, Urvi A.; Tan, Carlyn; Chung, David J.; Lahoud, Oscar B.; Hassoun, Hani; Lesokhin, Alexander M.; Landau, Heather J.; Shah, Gunjan; Scordo, Michael; Giralt, Se...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 14(2022)
Page Start:
3488
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach. Issue 3 (1st January 2023)

Authors:
Pianko, Matthew J.; Tiutan, Timothy; Derkach, Andriy; Flynn, Jessica; Salvatore, Steven P.; Jaffer‐Sathick, Insara; Rossi, Adriana C.; Lahoud, Oscar; Hultcrantz, Malin; Shah, Urvi A.; Maclachlan, Kylee; Chung, David J.; Shah, Gunjan L.; Landau, Heather J.; Korde, Neha; Mailankody, Sham; Lesokhin,...
Journal:
American journal of hematology
Issue:
Volume 98:Issue 3(2023)
Page Start:
421
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis. (15th August 2021)

Authors:
Piedra, Katrina; Peterson, Tim; Tan, Carlyn; Orozco, Jennifer; Hultcrantz, Malin; Hassoun, Hani; Mailankody, Sham; Lesokhin, Alexander; Shah, Urvi; Lu, Sydney; Patel, Dhwani; Derkach, Andriy; Wilkins, Cy R.; Korde, Neha
Journal:
British journal of haematology
Issue:
Volume 196:Number 1(2022)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features. (June 2022)

Authors:
Epstein-Peterson, Zachary D.; Spitzer, Barbara; Derkach, Andriy; Arango, Juan E.; McCarter, Joseph G.W.; Medina-Martínez, Juan S.; McGovern, Erin; Farnoud, Noushin Rahnamay; Levine, Ross L.; Tallman, Martin S.
Journal:
Leukemia research
Issue:
Volume 117(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial. Issue 6 (June 2021)

Authors:
Diamond, Benjamin; Korde, Neha; Lesokhin, Alexander M; Smith, Eric L; Shah, Urvi; Mailankody, Sham; Hultcrantz, Malin; Hassoun, Hani; Lu, Sydney X; Tan, Carlyn; Rustad, Even H; Maura, Francesco; Maclachlan, Kylee; Peterson, Tim; Derkach, Andriy; Devlin, Sean; Landau, Heather J; Scordo, Michael; C...
Journal:
Lancet
Issue:
Volume 8:Issue 6(2021)
Page Start:
e422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy of FLT3 and IDH1/2 inhibitors in patients with acute myeloid leukemia previously treated with venetoclax. (November 2022)

Authors:
Bewersdorf, Jan Philipp; Shallis, Rory M.; Derkach, Andriy; Goldberg, Aaron D.; Stein, Anthony; Stein, Eytan M.; Marcucci, Guido; Zeidan, Amer M.; Shimony, Shai; DeAngelo, Daniel J.; Stone, Richard M.; Aldoss, Ibrahim; Ball, Brian J.; Stahl, Maximilian
Journal:
Leukemia research
Issue:
Volume 122(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗